logo
Electra

Study ELECTRA-SIRIO 2

Evaluation of safety and efficacy of two ticagrelor-based platelet de-escalation strategies in acute coronary syndrome.

RANDOMIZED, MULTICENTER, DOUBLE-BLIND CLINICAL TRIAL

Dear Sir/Madam,

We invite you to participate in a clinical trial whose main objective is to evaluate and compare the clinical safety of two ticagrelor-based platelet de-escalation strategies with standard dual antiplatelet therapy (DAPT).

To start entering data from patient observations, please log in.

Electra

Log in to the eCRF system